6660 — AIM Vaccine Co Income Statement
0.000.00%
Last trade - 00:00
- HK$9.99bn
- HK$11.40bn
- CNY1.19bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 952 | 1,638 | 1,570 | 1,264 | 1,187 |
Cost of Revenue | |||||
Gross Profit | 733 | 1,354 | 1,295 | 1,028 | 901 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 784 | 1,136 | 2,166 | 1,673 | 3,414 |
Operating Profit | 168 | 502 | -596 | -408 | -2,227 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 157 | 486 | -607 | -434 | -2,271 |
Provision for Income Taxes | |||||
Net Income After Taxes | 120 | 400 | -676 | -231 | -1,950 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 117 | 379 | -693 | -320 | -1,301 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 117 | 379 | -693 | -320 | -1,301 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.1 | 0.317 | -0.571 | -0.223 | -0.12 |